# Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)

> **NCT00201292** · — · UNKNOWN · sponsor: **National Health Research Institutes, Taiwan** · enrollment: 1350 (estimated)

## Conditions studied

- Metabolic Syndrome
- Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00201292
- **Lead sponsor:** National Health Research Institutes, Taiwan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** 2008-10
- **Target enrollment:** 1350 (ESTIMATED)
- **Last updated:** 2007-11-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00201292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00201292, "Pharmacogenetic Profiling of Antipsychotics-Induced X-Syndrome and Diabetes (PAXD)". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00201292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*